"In our laboratory models, in our mouse models, the mice were cured ... Initially, the trial will recruit patients with HER2-driven tumors expressing the p95HER2 protein who have exhausted ...

Background: Variable rates of HER2 protein overexpression and gene amplification have been reported in advanced ovarian cancers (AOC). Trastuzumab, tested only as a single agent, has been shown to ...